awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37602310-159635CB-0C70-4A16-9334-7E2022FCA464
Q37602310-159635CB-0C70-4A16-9334-7E2022FCA464
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37602310-159635CB-0C70-4A16-9334-7E2022FCA464
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study.
P2093
Q37602310-159635CB-0C70-4A16-9334-7E2022FCA464
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37602310-159635CB-0C70-4A16-9334-7E2022FCA464
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c6e152f9eeab4338a2ef4d62786b7d4641076f0
P1545
9
http://www.w3.org/2001/XMLSchema#string
P2093
Ping Wang
http://www.w3.org/2001/XMLSchema#string